As mentioned before, Greene et al. highlighted that SIRT5 protects GLS from ubiquitination and consequent proteasomal degradation, increasing glutamine catabolism and producing α-KG, which contributes to ATP production since it is part of the TCA cycle, finally supporting cancer cell proliferation [70]. The gene discussed is SIRT5; the disease is cancer.